In the last twenty years, substantial endeavors have been devoted to evaluating the effectiveness of cancer antigen 125 (CA125), a tumor marker, and ultrasound scanning as a means of screening for ovarian cancer [14,15,16]. This evidence concerns the gene MUC16 and neoplasm.